The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population
- 31 May 2007
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 212 (3) , 572-578
Abstract
Abnormal differentiation in epithelial stem cells or their immediate proliferative progeny, the transiently amplifying population (TAP), may explain malignant pathogenesis in the human prostate. These models are of particular importance as differing sensitivities to androgen among epithelial cell subpopulations during differentiation are recognised and may account for progression to androgen independent prostate cancer. Androgens are crucial in driving terminal differentiation and their indirect effects via growth factors from adjacent androgen responsive stroma are becoming better characterised. However, direct effects of androgen on immature cells in the context of a prostate stem cell model have not been investigated in detail and are studied in this work. In α2β1hi stem cell enriched basal cells, androgen analogue R1881 directly promoted differentiation by the induction of differentiation-specific markers CK18, androgen receptor (AR), PSA and PAP. Furthermore, treatment with androgen down-regulated α2β1 integrin expression, which is implicated in the maintenance of the immature basal cell phenotype. The α2β1hi cells were previously demonstrated to lack AR expression and the direct effects of androgen were confirmed by inhibition using the anti-androgen bicalutamide. AR protein expression in α2β1hi cells became detectable when its degradation was repressed by the proteosomal inhibitor MG132. Stratifying the α2β1hi cells into stem (CD133+) and transient amplifying population (TAP) (CD133−) subpopulations, AR mRNA expression was found to be restricted to the CD133− (TAP) cells. The presence of a functional AR in the TAP, an androgen independent subpopulation for survival, may have particular clinical significance in hormone resistant prostate cancer, where both the selection of immature cells and functioning AR regulated pathways are involved. J. Cell. Physiol. 212:572–578, 2007.Keywords
This publication has 42 references indexed in Scilit:
- Androgens Induce Increases in Intracellular Calcium Via a G Protein—Coupled Receptor in LNCaP Prostate Cancer CellsJournal of Andrology, 2006
- Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem CellsCancer Research, 2006
- Prostate cancer stem cellsEuropean Journal of Cancer, 2006
- Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone‐refractory prostate cancerJournal of Cellular Biochemistry, 2006
- KGF suppresses α2β1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epitheliumJournal of Cell Science, 2006
- Prostate epithelial stem cellsCell Proliferation, 2005
- Mitogen‐activated protein kinase pathway is involved in androgen‐independent PSA gene expression in LNCaP cellsThe Prostate, 2003
- Keratinocyte growth factor activates p38 MAPK to induce stress fibre formation in human prostate DU145 cellsOncogene, 2001
- REGULATION OF KERATINOCYTE GROWTH FACTOR RECEPTOR AND ANDROGEN RECEPTOR IN EPITHELIAL CELLS OF THE HUMAN PROSTATEJournal of Urology, 2001
- Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostateJournal of Endocrinology, 1999